MICROBOT MEDICAL INC.

Microbot Medical Leverages Recently Awarded Non-Dilutive Grant from the Israeli Government to Promote Marketing Activities Toward Commercialization of the LIBERTY® Robotic System

02 Mar 2023 09:00:00 By Nasdaq GlobeNewswire

Microbot Medical Meeting with Key Opinion Leaders, Hospital Administrators, and Potential Strategic and Commercial Partners at the Society of Interventional Radiologist Annual Meeting

28 Feb 2023 09:00:01 By Nasdaq GlobeNewswire

Microbot Medical Expands its Geographic Presence to South America with the Addition of Francisco C. Carnevale, MD, PhD, FSIR to its Scientific Advisory Board

27 Feb 2023 09:00:00 By Nasdaq GlobeNewswire

Microbot Medical’s Remote Controller for the LIBERTY® Robotic System Receives Design Patent Allowance in Japan

23 Feb 2023 08:00:02 By Nasdaq GlobeNewswire

Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next “Access-Ability Live by MBOT” Webinar Series

31 Jan 2023 07:30:00 By Nasdaq GlobeNewswire

Microbot Medical Announces MedTech Industry Veteran Joe Mullings will Moderate the Next ‘Access-Ability Live by MBOT’ Webinar

06 Jan 2023 07:00:00 By Nasdaq GlobeNewswire

Microbot Medical Announces the Participation of a Key Opinion Leader in the Endovascular Robotics Space at the Next “Access-Ability Live by MBOT” Webinar Series

14 Dec 2022 08:30:00 By Nasdaq GlobeNewswire

Microbot Medical’s Proprietary LIBERTY® Robotic System Receives Third Patent Allowance in Israel

08 Dec 2022 07:00:00 By Nasdaq GlobeNewswire

Microbot Medical’s Novel LIBERTY® Robotic System Continues to be Validated with Latest U.S. Design Patent Allowance

18 Nov 2022 09:00:00 By Nasdaq GlobeNewswire

Microbot Medical Announces New Webinar Series to Engage Stakeholders with Experts in the Healthcare Space

15 Nov 2022 07:00:00 By Nasdaq GlobeNewswire

Microbot Medical Receives Additional Patent Allowance in Israel for the LIBERTY® Robotic System

03 Nov 2022 07:00:02 By Nasdaq GlobeNewswire

Microbot Medical Adds the Head of the Interventional Radiology Unit of Europe’s Largest Cancer Center, Dr. Thierry Jacques De Baère to its Scientific Advisory Board

31 Oct 2022 07:00:00 By Nasdaq GlobeNewswire

Microbot Medical Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

25 Oct 2022 16:01:00 By Nasdaq GlobeNewswire

Microbot Medical Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

21 Oct 2022 08:00:00 By Nasdaq GlobeNewswire

Microbot Medical Accomplishes the Next-Step in the Regulatory Process for the LIBERTY® Robotic System

18 Oct 2022 08:45:00 By Nasdaq GlobeNewswire

Microbot Medical Completes GLP Animal Study for the LIBERTY® Robotic System

13 Oct 2022 09:15:00 By Nasdaq GlobeNewswire

Microbot Medical Enhances Strategic Focus on its Endovascular Solutions

11 Oct 2022 09:00:01 By Nasdaq GlobeNewswire

Microbot Medical Receives Patent Allowance in Israel for the LIBERTY® Robotic System

10 Oct 2022 07:00:00 By Nasdaq GlobeNewswire

Microbot Medical Strengthens LIBERTY® Robotic System Portfolio with Acquisition of Novel FDA-Cleared Devices

07 Oct 2022 08:36:43 By Nasdaq GlobeNewswire

Microbot Medical Announce Strategic Addition to Scientific Advisory Board Appointment

04 Oct 2022 08:30:00 By Nasdaq GlobeNewswire